CELL BIOLOGY OF OVARIAN APOLIPOPROTEIN E
卵巢载脂蛋白 E 的细胞生物学
基本信息
- 批准号:2200252
- 负责人:
- 金额:$ 8.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-05-01 至 1995-09-30
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresis active sites affinity chromatography androgen inhibitor apolipoproteins autoradiography binding proteins cell differentiation chemical binding cyclic AMP graafian follicles granulosa cell human tissue immunocytochemistry in situ hybridization iodine laboratory rabbit laboratory rat ligands low density lipoprotein messenger RNA ovary peptide analog plasma protein biosynthesis protein structure function radionuclides radiotracer steroid hormone biosynthesis tissue /cell culture
项目摘要
Apoprotein (apo) E is a well-characterized protein whose
acknowledged function is to mediate the transport and uptake of
cholesterol-rich plasma lipoproteins. Incongruous with this role in
cholesterol homeostasis is the repeated observation that apo E is also
synthesized in multiple extrahepatic sites including ovarian granulosa
cells. While investigating the lipoprotein requirements of ovary
androgen producing cells, I discovered that apo E is a specific inhibitor
of androgen synthesis. In the presence of apo E, cultured LH-stimulated
theca/interstitial (T/I) cells make progesterone, but cannot convert it
to androgen. Furthermore, I have recently identified a synthetic peptide
analogue of apo E that is capable of mimicking intact apo E. Granulosa
cells and theca cells are dependent on one another to coordinate the
production of estrogen that is critical in controlling follicular
development. To test the hypothesis that granulosa cell apo E is an
intraovarian regulator of T/I cell androgen production, five Specific
Aims will be accomplished. The first is to demonstrate that granulosa
cell-derived apo E inhibits T/I cell androgen production. Apo E will be
isolated from granulosa cell culture supernatants and tested for biologic
activity. The second Specific Aim is to characterize the changes in
ovarian apo E content, apo E synthesis, and apo E binding during
follicular development. Using immunohistochemical and autoradiographic
techniques, apo E and its binding sites will be identified in follicles
at different stages of development. In addition, cells expressing apo E
mRNA will be identified by In situ hybridization. The third Specific Aim
is to characterize the interaction of apo E with cultured T/I cells and
to identify the molecular nature of the cellular binding sites. Using
both granulosa cell-derived apo E and a synthetic apo E peptide analogue,
binding to T/I cells will be characterized. The fourth Specific Aim is
to define the structural features of apo E that are responsible for its
binding to and biologic effect on T/I cells. Chemical modifications and
amino acid substitutions will be made in the apo E synthetic peptide to
define the structural requirements for both binding and function. The
fifth Specific Aim is to identify the site of the inhibitory activity of
apo E pre- and post-cAMP mediation of theca/interstitial cell
differentiation. Based on the information obtained from this
investigation, it will be possible to assess the physiologic role of
granulosa cell apo E in ovarian function.
丙蛋白(apo)E是一种良好的蛋白质
公认的功能是调解运输和吸收
富含胆固醇的血浆脂蛋白。 与这个角色不协调
胆固醇稳态是反复观察到apo e也是
在包括卵巢颗粒在内的多个肝外部位合成
细胞。 在研究卵巢的脂蛋白需求时
雄激素产生细胞,我发现apo e是一种特定的抑制剂
雄激素合成。 在apo e的存在下,培养的LH刺激
theca/间质(T/I)细胞会产生孕激素,但无法转换
到雄激素。 此外,我最近确定了合成肽
能够模仿完整apo E.颗粒的apo e的类似物
细胞和theca细胞彼此依赖以协调
产生雌激素,这对于控制卵泡至关重要
发展。 测试颗粒细胞apo e的假设是
T/I细胞雄激素产生的载体内调节剂,五个特异性
目标将实现。 首先是证明颗粒
细胞来源的Apo E抑制T/I细胞雄激素的产生。 apo e将会
从颗粒细胞培养上清液中分离并测试生物学
活动。 第二个具体目的是表征变化
卵巢apo e含量,apo e合成和apo e在期间结合
卵泡发展。 使用免疫组织化学和放射自显影
技术,apo e及其结合位点将在卵泡中识别
在不同的发展阶段。 另外,表达apo e的细胞
mRNA将通过原位杂交识别。 第三个特定目标
是为了表征Apo e与培养的T/I细胞的相互作用以及
确定细胞结合位点的分子性质。 使用
颗粒细胞衍生的apo e和合成apo e肽模拟,
将表征与T/I细胞的结合。 第四个特定目标是
定义apo e的结构特征
与T/I细胞的结合和生物学作用。 化学修饰和
将在Apo e合成肽中进行氨基酸取代
定义结合和功能的结构要求。 这
第五个具体目的是确定
theca/间质细胞的训练前和训练后调解
分化。 根据从此获得的信息
调查,可以评估
卵巢功能中的颗粒状细胞apo e。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHERYL A DYER其他文献
CHERYL A DYER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHERYL A DYER', 18)}}的其他基金
ContraPest-an oral bait for fertility management of rodent pests
ContraPest-一种用于啮齿类害虫生育管理的口服诱饵
- 批准号:
7804189 - 财政年份:2011
- 资助金额:
$ 8.26万 - 项目类别:
Estrogenic activity of uranium in vitro and in vivo
铀的体外和体内雌激素活性
- 批准号:
6848611 - 财政年份:2005
- 资助金额:
$ 8.26万 - 项目类别:
Estrogenic activity of uranium in vitro and in vivo
铀的体外和体内雌激素活性
- 批准号:
7120248 - 财政年份:2005
- 资助金额:
$ 8.26万 - 项目类别:
Estrogenic activity of uranium in vitro and in vivo
铀的体外和体内雌激素活性
- 批准号:
7213486 - 财政年份:2005
- 资助金额:
$ 8.26万 - 项目类别:
相似海外基金
Mechanisms of 3' Splice Site Selection in S. cerevisiae
酿酒酵母 3 剪接位点选择机制
- 批准号:
6688999 - 财政年份:2002
- 资助金额:
$ 8.26万 - 项目类别:
Mechanisms of 3' Splice Site Selection in S. cerevisiae
酿酒酵母 3 剪接位点选择机制
- 批准号:
6421794 - 财政年份:2002
- 资助金额:
$ 8.26万 - 项目类别:
Mechanisms of 3' Splice Site Selection in S. cerevisiae
酿酒酵母 3 剪接位点选择机制
- 批准号:
6620793 - 财政年份:2002
- 资助金额:
$ 8.26万 - 项目类别:
Mechanisms of 3' Splice Site Selection in S. cerevisiae
酿酒酵母 3 剪接位点选择机制
- 批准号:
6833484 - 财政年份:2002
- 资助金额:
$ 8.26万 - 项目类别:
Proteomic Dissection of M-channel Phosphorylation
M通道磷酸化的蛋白质组学解析
- 批准号:
6529992 - 财政年份:2001
- 资助金额:
$ 8.26万 - 项目类别: